Adial Pharmaceuticals
ADIL
8 hedge funds and large institutions have $1.48M invested in Adial Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
62% more capital invested
Capital invested by funds: $917K → $1.48M (+$564K)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
20% less funds holding
Funds holding: 10 → 8 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$10.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$2K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $682K | – | – | – |
|
2
BlackRock
New York
| $496K | – | – | – |
|
3
Geode Capital Management
Boston,
Massachusetts
| $187K | – | – | – |
|
4
Brown Advisory
Baltimore,
Maryland
| $63K | – | – | – |
|
5
Commonwealth Equity Services
Waltham,
Massachusetts
| $25K | – | – | – |
|
|
LTFS
6
Ladenburg Thalmann Financial Services
Miami,
Florida
| $25K | +$10.5K | +10 | +143% |
|
7
Wells Fargo
San Francisco,
California
| $2K | – | – | – |
|
8
Morgan Stanley
New York
| $1K | – | – | – |
|
|
9
Victory Capital Management
San Antonio,
Texas
| – | -$2K | -2 | Closed |
|
|
10
Bank of America
Charlotte,
North Carolina
| – | -$1K | -1 | Closed |
|
ADIL Hedge Fund Activity: Q4 2019 in Review
8 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals (ADIL) for Q4 2019, worth a combined $1.48M — up 62% from $917K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ADIL and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Ladenburg Thalmann Financial Services, adding an estimated $10.5K. The largest seller was Victory Capital Management, exiting entirely with an estimated $2K sold.
- 8 institutional investors held Adial Pharmaceuticals (ADIL) as of Q4 2019, down from 10 in Q3 2019.
- Funds reported $1.48M of Adial Pharmaceuticals stock for Q4 2019, up 62% quarter-over-quarter.
- 0 funds opened new Adial Pharmaceuticals positions in Q4 2019 and 2 closed out, a net change of -2 holders.
- The largest Adial Pharmaceuticals buyer in Q4 2019 was Ladenburg Thalmann Financial Services, an estimated $10.5K added.
- The largest Adial Pharmaceuticals seller in Q4 2019 was Victory Capital Management, an estimated $2K sold.
Based on aggregated 13F filings for Q4 2019.